Stay updated with breaking news from Gsk chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
13.11.2023 - GSK plc (LSE/NYSE: GSK) has partnered with former Queer Eye star and interior designer Thom Filicia to launch Mapping Myelofibrosis, a new health education initiative aiming to help those impacted by myelofibrosis (MF) better navigate the disease. . Seite 1 ....
16.09.2023 - GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis . Seite 1 ....